Generic name:sotorasib
Dosage form: tablets
Drug class:Miscellaneous antineoplastics
What is Lumakras?
Lumakras is a prescription medicine used to treat adults with non-small cell lung cancer (NSCLC):
- that has spread to other parts of the body or cannot be removed by surgery, and
- whose tumor has an abnormal KRAS G12C gene, and
- who have received at least one prior treatment for their cancer.
Your healthcare provider will perform a test to make sure that Lumakras is right for you.
It is not known if this medicine is safe and effective in children.
Before taking Lumakras
Before you start treatment, tell your healthcare provider about all your medical conditions, including if you:
- have liver problems
- have lung or breathing problems other than lung cancer
- are pregnant or plan to become pregnant. It is not known if Lumakras will harm your unborn baby.
- are breastfeeding or plan to breastfeed. It is not known if Lumakras passes into your breast milk. Do not breastfeed during treatment, and for 1 week after the final dose.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, dietary and herbal supplements. Lumakras can affect the way some other medicines work, and some other medicines can affect the way Lumakras works.
Especially tell your healthcare provider if you take antacid medicines, including Proton Pump Inhibitor (PPI) medicines or H2 blockers during treatment. Ask your healthcare provider if you are not sure.
How should I take Lumakras?
- Take Lumakras exactly as your healthcare provider tells you to take it. Do not change your dose or stop taking Lumakras unless your healthcare provider tells you to.
- Take Lumakras tablets 1 time each day, at about the same time each .
